期刊文献+

紫铆因抑制膀胱癌细胞增殖的体内外研究 被引量:8

Butein Inhibits Cell Proliferation of Bladder Cancer in vitro and in vivo
下载PDF
导出
摘要 目的观察紫铆因对膀胱移行细胞癌细胞BLS增殖的影响以及对膀胱癌裸鼠移植瘤生长的影响。方法不同浓度紫铆因处理细胞,四甲基偶氮唑蓝比色实验(MTT)及平板克隆形成实验观察细胞增殖能力,流式细胞仪分析细胞周期,蛋白印迹检测核转录因子κB(NF-κB)p65核内表达及细胞外信号调节激酶1/2(ERK1/2)的磷酸化程度,并检测NF-κB下游靶基因细胞周期素D1(Cyclin D1)及环氧合酶-2(COX2)的表达。建立膀胱癌裸鼠皮下移植瘤,采用腹腔注射的给药途径,测量移植瘤的体积和重量。结果紫铆因抑制了膀胱癌细胞增殖并诱导G2/M期细胞周期阻滞。紫铆因处理后NF-κB p65的核内表达及ERK1/2的磷酸化程度下降(P<0.05),Cyclin D1及COX2基因表达下调(P<0.05),体内实验发现紫铆因治疗组较对照组皮下移植瘤的生长明显受抑制(P<0.05)。结论紫铆因具有抗膀胱癌细胞增殖作用,可能与其抑制ERK及NF-κB信号激活有关。 Objective To investigate the effects of Butein on proliferation of BLS cells in human bladder transitional cell carcinoma(BTCC) in vitro and on transplantation tumor growth of bladder carcinoma in nude mice. Methods BLS cells were treated with Butein at various concentrations. Cell proliferation was analyzed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide(MTT)assay and clone formation assay, and cell cycle was detected by flow cytometry. Western blot was applied to measure phosphorylation of extra cellular signal regulated kinase(ERK1/2), nuclear transcription factor kappa B(NF-κB) p65 expression, Cyclin D1 and COX2 expressions in downstream target genes of NF-κB. Transplanted tumors of bladder cancer in nude mice were constructed. Administration route was intraperitoneal injection. Volume and weight of transplanted tumors were measured. Results Butein inhibited cell growth and induced G2/M cell cycle arrest in bladder cancer cells. Phosphorylation of ERK1/2 and NF-κB p65 intranuclear expression were reduced(P<0.05); Protein expressions of Cyclin D1 and COX2 were decreased(P<0.05); Growth of transplant subcutaneous tumor in treatment group was obviously inhibited(P<0.05). Conclusion Butein has anti-proliferation effect on human bladder cancer cells in vitro and in vivo possibly through suppressing ERK and NF-κB activation.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2014年第7期714-718,共5页 Cancer Research on Prevention and Treatment
基金 陕西省科技攻关项目资助课题(2012SF2-03) 西安市科技计划项目资助课题(SF1204(5b))
关键词 紫铆因 膀胱移行细胞癌 增殖 Butein bladder transitional cell carcinoma(BTCC) Proliferation
  • 相关文献

参考文献5

  • 1杨玉琮,李旭,陈葳.免疫相关基因在同一膀胱癌亚克隆细胞株中的差异表达[J].细胞与分子免疫学杂志,2006,22(5):625-627. 被引量:4
  • 2马艳霞,李敏.NF-κB与肿瘤防治药物研究进展[J].肿瘤防治研究,2006,33(6):465-467. 被引量:2
  • 3Angeline Wei Ling Chua,Hui Sin Hay,Peramaiyan Rajendran,Muthu K. Shanmugam,Feng Li,Pradeep Bist,Evelyn S.C. Koay,Lina H.K. Lim,Alan Prem Kumar,Gautam Sethi.Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-κB activation in breast and pancreatic tumor cells[J].Biochemical Pharmacology.2010(10)
  • 4Grace Tak Yi Lau,Hui Huang,Shu-mei Lin,Lai K. Leung.Butein downregulates phorbol 12-myristate 13-acetate-induced COX-2 transcriptional activity in cancerous and non-cancerous breast cells[J].European Journal of Pharmacology.2010(1)
  • 5Er-Bin Yang,Kai Zhang,Li Yao Cheng,Peter Mack.Butein, a Specific Protein Tyrosine Kinase Inhibitor[J].Biochemical and Biophysical Research Communications.1998(2)

二级参考文献33

  • 1张晓文,王立新,姚茂银,肖家全.联合应用卡介苗有效成分——罗莫肽和CpG-ODN刺激人PBMC分泌细胞因子[J].细胞与分子免疫学杂志,2004,20(5):602-603. 被引量:2
  • 2马艳霞,徐波,崔景荣,王鹂,吴军,李敏.以NF-_κB为靶的药物筛选方法的建立与应用研究[J].生物化学与生物物理进展,2006,33(2):149-154. 被引量:9
  • 3Yamamoto Y,Gaynor RB. Role of the NF-kappaB pathway in the pathogenesis of human disease states[J]. Curr Mol Med,2001,1 (3) : 287-296.
  • 4Nakanishi C,Toi M. Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs[J].Nat Rev Cancer, 2005, 5 (4):297-309.
  • 5Mayo MW, Baldwin AS. The transcription factor NF-kappaB:control of oncogenesis and cancer therapy resistance[J]. Biochim Biophys Acta, 2000, 1470(2): M55-62.
  • 6Phal HL. Activators and target genes of Rel/NF-kappaB transcription factors[J]. Oncogene, 1999, 18 (49): 6853-6866.
  • 7Orlowski RZ, Baldwin AS Jr. NF-kappaB as a therapeutic target in cancer[J].Trends Mol Med, 2002, 8(8) : 385-389.
  • 8Mclntyre KW, Shuster DJ,Gillooly KM, et al. A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice[J]. Arthritis Rheum, 2003, 48(9) :2652-2659.
  • 9Adams J. Preclinical and clinical evaluation of proteasome inhibitor PS-341 for the treatment of cancer [J].Curr Opin Chem Biol, 2002, (4): 493-500.
  • 10Boccadoro M,Morgan G, Cavenagh J. Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy[J].Cancer Cell Int, 2005, 5(1 ) : 18.

共引文献4

同被引文献185

引证文献8

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部